Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
University of Calgary
Headquarters: Calgary, AB, Canada
Website: http://www.ucalgary.ca
Year Founded: 1966
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Jan 1, 2021
Targets & Mechanisms
A snapshot of target innovation in 2020
An analysis of BioCentury’s Distillery captures trends from preclinical publications in 2020
BioCentury | Oct 28, 2020
Distillery Therapeutics
Inhibiting IL-33-driven inflammation to treat brain cancer
DISEASE CATEGORY: Cancer
INDICATION: Brain cancer Targeting nuclear accumulation of IL-33 could treat glioblastoma multiforme by reducing recruitment of pro-tumorigenic innate immune cells to the
INDICATION: Brain cancer Targeting nuclear accumulation of IL-33 could treat glioblastoma multiforme by reducing recruitment of pro-tumorigenic innate immune cells to the
BioCentury | Apr 15, 2019
Distillery Therapeutics
MedImmune's bispecific mAb for Pseudomonas-related ocular keratitis
BioCentury | Jul 19, 2018
Translation in Brief
Inflammatory images
How inflammasome activation mediates contrast agent-induced acute kidney injury
Items per page:
1 - 10 of 57